New Zealand markets closed

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
30.47+0.62 (+2.08%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 7.57B
Enterprise value 7.14B
Trailing P/E 40.63
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.68
Price/book (mrq)4.85
Enterprise value/revenue 7.71
Enterprise value/EBITDA 30.44

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 353.17%
S&P500 52-week change 326.49%
52-week high 330.50
52-week low 319.37
50-day moving average 326.42
200-day moving average 326.09

Share statistics

Avg vol (3-month) 31.13M
Avg vol (10-day) 31.48M
Shares outstanding 5248.53M
Implied shares outstanding 6248.87M
Float 889.18M
% held by insiders 169.71%
% held by institutions 18.28%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.17
Forward annual dividend yield 40.56%
Trailing annual dividend rate 30.24
Trailing annual dividend yield 30.80%
5-year average dividend yield 4N/A
Payout ratio 422.67%
Dividend date 3N/A
Ex-dividend date 401 Jun 2023
Last split factor 21.4:1
Last split date 301 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 21.83%
Operating margin (ttm)23.79%

Management effectiveness

Return on assets (ttm)8.62%
Return on equity (ttm)13.70%

Income statement

Revenue (ttm)925.89M
Revenue per share (ttm)3.76
Quarterly revenue growth (yoy)29.60%
Gross profit (ttm)N/A
EBITDA 266.38M
Net income avi to common (ttm)202.08M
Diluted EPS (ttm)0.75
Quarterly earnings growth (yoy)20.50%

Balance sheet

Total cash (mrq)493.36M
Total cash per share (mrq)1.99
Total debt (mrq)63.7M
Total debt/equity (mrq)4.08%
Current ratio (mrq)2.77
Book value per share (mrq)6.28

Cash flow statement

Operating cash flow (ttm)200.84M
Levered free cash flow (ttm)-10.86M